InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
janeyH Free
03/07/24 8:57 AM
profile icon
janeyH Free
02/29/24 9:06 AM
profile icon
janeyH Free
02/28/24 2:27 PM
profile icon
janeyH Free
02/23/24 12:08 PM
profile icon
janeyH Free
02/22/24 9:21 AM
profile icon
janeyH Free
02/21/24 8:33 AM
profile icon
MikeyInTheD Free
02/20/24 10:27 PM
profile icon
janeyH Free
02/20/24 3:26 PM
profile icon
janeyH Free
02/20/24 3:16 PM
profile icon
MikeyInTheD Free
02/20/24 2:46 PM
profile icon
janeyH Free
02/20/24 11:58 AM
profile icon
janeyH Free
01/23/24 9:41 AM
profile icon
DrZSmith Free
01/16/24 9:20 AM
profile icon
janeyH Free
01/10/24 9:19 AM
profile icon
janeyH Free
01/03/24 10:14 AM
profile icon
janeyH Free
01/02/24 1:59 PM
profile icon
janeyH Free
12/22/23 11:11 AM
profile icon
janeyH Free
12/14/23 2:34 PM
profile icon
janeyH Free
11/21/23 2:21 PM
profile icon
janeyH Free
11/17/23 2:57 PM
profile icon
janeyH Free
11/15/23 11:17 AM
profile icon
janeyH Free
11/09/23 9:56 AM
profile icon
janeyH Free
10/31/23 12:38 PM
profile icon
janeyH Free
10/31/23 12:38 PM
profile icon
kellyemmerson Free
10/16/23 10:46 AM
profile icon
janeyH Free
10/13/23 11:12 AM
profile icon
janeyH Free
09/28/23 9:50 AM
profile icon
janeyH Free
09/26/23 1:57 PM
profile icon
DrZSmith Free
09/13/23 3:22 PM
profile icon
thumper1 Free
08/25/23 3:16 PM
profile icon
DrZSmith Free
08/12/23 8:45 AM
profile icon
janeyH Free
08/11/23 4:10 PM
profile icon
DrZSmith Free
08/11/23 1:44 PM
profile icon
janeyH Free
08/11/23 1:22 PM
profile icon
janeyH Free
08/11/23 9:06 AM
profile icon
thumper1 Free
08/01/23 3:26 PM
profile icon
thumper1 Free
08/01/23 3:18 PM
profile icon
AJ Freely Free
08/01/23 8:31 AM
profile icon
janeyH Free
07/20/23 2:20 PM
profile icon
janeyH Free
06/26/23 6:31 PM
profile icon
janeyH Free
06/07/23 11:43 AM
profile icon
janeyH Free
06/05/23 11:39 AM

Sanuwave Health Inc (SNWV) RSS Feed

Followers
29
Posters
156
Posts (Today)
0
Posts (Total)
2233
Created
03/18/10
Type
Free
Moderators janeyH

 

 

                                                                         dermaPACE®                                     orthoPACE®                                                            OssaTron®






Company Information
 

SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body's normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE®) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.

Headquartered in Alpharetta, GA, SANUWAVE designs, manufactures, markets, and services its industry leading products worldwide.

We have already demonstrated that this technology is safe and effective in the European community for the stimulation of bone and chronic tendonitis regeneration in the musculoskeletal environment.

Our lead development product for the global wound care market, dermaPACE, has received CE marking for use on acute and chronic defects of the skin and subcutaneous soft tissue. In the U.S. the dermaPACE has recently completed a pivotal Phase III, Investigational Device Exemption (IDE) study for the treatment of diabetic foot ulcers. The results were highly positive and clinically relevant.

Our musculoskeletal regenerative device, orthoPACE, launched in Europe for orthopedic, trauma and sports medicine indications in 2010.

We are now entirely focused on developing and commercializing this technology to stimulate tissue healing in all wound healing conditions to include DFU, decubitus ulcers (pressure sores), burns and other skin eruption conditions; orthopedic/spine applications such as fracture healing and fusion, creating improved bone density in osteoporosis and to eliminate chronic pain from trauma or arthritis; plastic/cosmetic applications such as cellulite smoothing, preconditioning for graft and transplant acceptance, skin tightening, scarring and other aesthetic uses; and potential developments in cardiac indications for removing plaque due to atherosclerosis and improving blood supply to the heart muscle. 




 





Company Management

Board of Directors

Christopher M. Cashman joined the Company as Chief Executive Officer and President in September of 2009 and as a director in October of 2009, and joined SANUWAVE, Inc. as President, Chief Executive Officer and a director in December of 2005. Mr. Cashman brings to our board of directors, among other skills and qualifications, a unique understanding of our strategies and operations through his years of experience with various public and private healthcare companies. Immediately prior to joining SANUWAVE, Inc., he served as President of Therapeutic Surfaces for Kinetic Concepts, Inc., a global leader in advanced wound care, from October of 2005 to December of 2005. In November of 2001, Mr. Cashman conducted a management buyout of Snowden Pencer, Inc., a minimally invasive surgical device manufacturer, and assumed the role of Chief Executive Officer and President until Snowden Pencer, Inc. was sold to Cardinal Health, Inc. in March 2004. Mr. Cashman also served as a business unit head with Genzyme Biosurgery and held several senior sales and marketing positions with Genzyme Surgical Products and Deknatel Snowden Pencer. Mr. Cashman graduated from the United States Naval Academy in 1989 with a B.S. in Economics and served on a fast attack submarine as Supply Officer. He received his M.B.A. in 2001 from the Kellogg Graduate School of Management at Northwestern University. 

Thomas H. Robinson joined the Company as a member of the board of directors in October of 2009 and joined SANUWAVE, Inc. as a member of the board of directors in August of 2005. Mr. Robinson brings to our board of directors experience based on his diverse experience with medical device companies both in providing executive search services to them as well as working for them in leadership and Director positions. Since 2010, Mr. Robinson has been a partner with Russell Reynolds Associates, a global executive search firm, in their global Medical Technology Practice leading senior executive searches. From 1998 to 2010, Mr. Robinson served as managing partner of Spencer Stuart, Inc.'s North American medical technology practice. From 1993 to 1997, Mr. Robinson served as President of the emerging markets business at Boston Scientific Corporation, a global medical devices manufacturer. From 1991 to 1993, Mr. Robinson served as President and Chief Operating Officer of Brunswick Biomedical, a cardiology medical device company. Mr. Robinson is also a member of the board of directors and is chairman of the compensation committee of Cynosure, Inc., a publicly traded aesthetic medical laser company. 

Kevin A. Richardson, II joined the Company as chairman of the board of directors in October of 2009 and joined SANUWAVE, Inc. as chairman of the board of directors in August of 2005. Mr. Richardson brings to our board of directors a broad array of financial knowledge for healthcare and other industries. Since 2004, Mr. Richardson has served as managing partner of Prides Capital LLC, an investment management firm. Mr. Richardson is also a member of the board of directors of eDiets.com, Inc., a publicly traded weight loss solutions company, and Pegasus Solutions, Inc., a travel technology company. 
 
John F. Nemelka  joined the Company as a member of the board of directors in October of 2009 and joined SANUWAVE, Inc. as a member of the board of directors in August of 2005. Mr. Nemelka brings to our board of directors a diverse financial and operational experience. Since 2001, Mr. Nemelka has served as a managing principal of NightWatch Capital Advisors, LLC, an investment management firm. Mr. Nemelka is also interim Chief Executive Officer and a member of the board of directors of SWK Holdings Corporation, a publicly traded holding company, formerly named KANA Software, Inc., a provider of customer service software solutions. 

Ronald M. Sparks, Jr. joined the Company as a member of the board of directors in September of 2011. Mr. Sparks brings extensive experience in the medical device industry, specifically in wound care and orthopedics. Mr. Sparks is the Chief Executive Officer and Chairman at Navilyst Medical, Inc., a best-in-class image-guided medical solutions company. He is also an Industry Executive at Avista Capital Holdings, L.P., a leading private equity firm. Previously, Mr. Sparks served as President, Chief Executive Officer and Executive Director for Accellent Inc., the largest provider of integrated contract manufacturing and design services to the medical device industry. In November 2005, Mr. Sparks led the sale of Accellent to the private equity firm Kohlberg Kravis Roberts & Co. in a transaction valued at approximately $1.3 billion. Prior to Accellent, Mr. Sparks had a 20-year career at Smith & Nephew, plc, where he was a Member of the Group Executive Committee and served as President of the Endoscopy Division from 1998 to 2003. Mr. Sparks served as the President of the Wound Management Division from 1995 to 1998. While at Smith & Nephew, Ron was integrally involved in the successful launch of Dermagraft®, a cell based therapy used to treat diabetic foot ulcers. He has served as Trustee of the Arthroscopy Association of North America (AANA) Education Foundation since 2006, is an Honorary Fellow of the American Sports Medicine Institute (ASMI) and is an honorary member of the International Society of Arthroscopy Knee Surgery and Orthopaedic Sports Medicine (ISAKOS). Mr. Sparks graduated from the University of Massachusetts at Amherst with a BA in Finance and Accounting, and completed the INSEAD Advanced Management Program in Fontainebleau, France. 
 
Barbara M. Henagan joined the Company as a member of the board of directors in September of 2011. Ms. Henagan has more than 30 years of direct private equity investing experience. She is a founding member of Linx Partners, a private equity investment firm that partners with family owners, entrepreneurs and management to acquire and grow middle-market industrial companies. Previously, she was Senior Managing Director of Bradford Ventures, Ltd. Ms. Henagan is Chairman of the Board of Metaltech Service Center, Inc. and is a member of the Board of Trustees of the Atlanta Speech School and the Atlanta Botanical Garden, where she previously served as Chairman. She is on the Board of Councilors of The Carter Center and is a member of the Goizueta Business School Advisory Board of Emory University. Ms. Henagan holds an MBA from Columbia University and a BA from Princeton University. 

Executive Profiles


Christopher M. Cashman, CEO 
 
Christopher M. Cashman joined SANUWAVE Health, an emerging leader in regenerative medicine, as Director, President and Chief Executive Officer in December, 2005. Immediately prior, he served as President of Therapeutic Surfaces for Kinetic Concepts, Inc, a global leader in advanced wound care. He conducted a management buyout in November 2001 of Snowden Pencer, a minimally invasive surgical device manufacturer, and assumed the role of CEO and President. In March 2004, Snowden Pencer was sold to Cardinal Health. Mr. Cashman has also served as a business unit head with Genzyme Biosurgery and held several senior sales and marketing positions with Genzyme Surgical Products and Deknatel Snowden Pencer. Mr. Cashman graduated from the United States Naval Academy in 1989 with a B.S. degree in Economics and served on a fast attack submarine as Supply Officer. He received his M.B.A. degree in 2001 from The Kellogg Graduate School of Management at Northwestern University.

Barry Jenkins, CFO
 
Barry Jenkins joined SANUWAVE as Chief Financial Officer in April 2006. His previous position was with Automatic Data Processing (ADP), where he served as Chief Financial Officer for the Benefits Services Division. Mr. Jenkins began his career with Price Waterhouse and progressed to a Senior Manager. He was the Vice President of Finance at AHL Services, a public company which grew to over $900 million during his tenure. As the Chief Financial Officer at Snowden Pencer, Mr. Jenkins helped grow the corporation prior to the company being sold to Cardinal Health in March, 2004. He is a Certified Public Accountant with 25 years of financial management experience and is a Cum Laude graduate of Virginia Tech.

Peter Stegagno, VP of Operations
 
Peter Stegagno joined SANUWAVE as Vice President, Operations in March 2006. Mr. Stegagno brings to SANUWAVE 16 years experience in the medical device market encompassing manufacturing, design & development, quality assurance and international & domestic regulatory affairs. He has been instr